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ABSTRACT
DUBOIS, KAYLA The Theia Soteria: Alternative Design for Safer Initial Entry During
Laparoscopic Procedures
Department of Biomedical Engineering
June 2019
ADVISORS: Jennifer Currey, Takashi Buma, and Shane Cotter
Laparoscopic procedures account for 15 million surgeries worldwide [1], with the
initial entry into the peritoneal cavity accounting for 33-50% of all major laparoscopic
complications [7]. This initial entry is the most dangerous as surgeons must enter the
cavity using a sharp object with no visibility and space between the outer surface of the
cavity and internal tissues. During the initial entry into the peritoneal cavity, the patients
undergoing laparoscopic procedures are at a high risk for damage to internal organs and
vasculature, necessitating the development of a device to protect these internal tissues
and increase patient safety.
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Background
Laparoscopic procedures account for 15 million surgeries worldwide and are becoming
the new standard for abdominal surgeries, such as cholecystectomies, appendectomies,
tubo-ovarian procedures, hysterectomies, bariatric procedures, gastrointestinal
procedures, urological cancer resections, and aortic aneurysms [1]. Laparoscopic
procedures are preferred to their open procedure counterparts because they provide
greater intraoperative visibility, are less expensive, and are less invasive, leading to
patients experiencing less pain, a shorter recovery time, less scarring, reduced blood loss,
and a shorter stay in the hospital [1][2]. The procedure is minimally invasive, requiring 4
to 5 small incisions ranging from 0.5cm to 1cm in length to access the abdomen [3]. The
small incisions, or ports, allow for the insertion of trocars which act as access points into
the abdominal cavity for surgical instruments and the laparoscope, or camera, that are
used throughout the procedure (Figure 1) [4].

Figure 1. Diagram of laparoscopic procedure. The surgical tools are inserted
through ports which act as access points for the remainder of the procedure [4].
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The initial entry during laparoscopic procedures is used to inflate the peritoneal cavity to
increase visibility for the remainder of the procedure. There are multiple methods for
achieving this initial entry, the two most common being entry using a Veress needle and
the open technique. The Veress needle is inserted into the peritoneal cavity, releases
carbon dioxide to inflate the cavity, then is removed and followed by the blind insertion
of a sharp trocar. The open, or Hasson technique, involves a larger incision for the trocar
to be inserted immediately without prior inflation of the cavity. Both techniques are
dangerous as a sharp instrument is being inserted without visualization and without a
preexisting pneumoperitoneum, or presence of gas within the peritoneal cavity [5]. Since
the abdomen has not been inflated, the distance between the skin surface and aorta can be
as low as 2 cm, leaving little room for error during the procedure [6]. Due to the lack of
visibility and low room for error, the initial insertion accounts for 33-50% of all major
laparoscopic complications [7]. These complications include, but are not limited to,
vascular, bowel, uterine, and bladder damage.
The Veress needle is the most commonly used technology for the initial entry into the
peritoneal cavity, as it requires a smaller incision for entry. The current design of the
Veress needle involves a cannula, which is an outer needle with a sharp distal point
designed to penetrate the tissues, with a spring-loaded inner stylet with a dull tip intended
to prevent damage when within body cavities (Figure 2).
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Figure 2. Current Veress needle design. (A) Outer cannula with
sharp beveled tip to penetrate tissues. (B) Inner stylet with hole
for release of carbon dioxide. (C) Spring in the handle to control
the position of the stylet.

The problem with the current Veress needles used in the operating room involves the lack
of effective components protecting the internal tissues from damage. Since the surgeon
cannot see into the cavity, they must rely on feel and their experience to determine if their
position in the cavity is correct; if their position is not correct and they continue with the
procedure, the patient is at risk for complications. There are currently two patents
available with design elements intended to alert the surgeon of their position within the
cavity, eliminating the risk for complications stemming from the lack of visibility.
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In a patent for a Veress needle with an illuminated tip and cavity penetration indicator,
the Veress needle is designed with an external light source on the surgeon’s end of the
assembly to indicate whether the device is within the abdominal cavity. The light will
turn off when the device has entered the cavity, as the switch is connected to the springloaded stylet; when the stylet is under pressure and the spring is compressed, the light
will be on. When the stylet is no longer under pressure, and the spring is relaxed, the light
will turn off, signaling to the surgeon that the insufflation process can safely begin [8].
The other useful patent for determining location within the cavity is a proximity detector
paired with a medical instrument. The patent outlines the usage of the detector on the end
of a medical instrument that determines the distance between the instrument and “an
internal organ or member such as an artery” through the use of a transducer capable of
sensing pressure changes [9]. While this technology was designed for use with general
medical instruments, it can be adapted for use with a Veress needle to indicate the
surgeon’s position within the peritoneal cavity.
Neither of these patents are currently being used. The current Veress needle alerts the
surgeon of their position within the cavity by either having a transparent handle, showing
whether the spring is compressed, or by a red indicator that slides out of the top of the
handle, indicating when the needle is under pressure.

Problem Statement
Laparoscopic procedures account for 15 million surgeries worldwide [1], with the initial
entry into the peritoneal cavity accounting for 33-50% of all major laparoscopic
complications [7]. This initial entry is the most dangerous as surgeons must enter the
4

cavity using a sharp object with no visibility and space between the outer surface of the
cavity and internal tissues. During the initial entry into the peritoneal cavity, the
patients undergoing laparoscopic procedures are at a high risk for damage to
internal organs and vasculature, necessitating the development of a device to protect
these internal tissues and increase patient safety.

Design Objectives
Objectives and sub-objectives were established for the device (Table 1). To determine
which objectives were critical to the design of our device, we considered what the
currently technology achieves successfully, as well as where it falls short. Since the
current technology results in operator mistakes that may lead to patient complications, the
main objectives of our device were determined to be safe, user friendly, and marketable.
Table 1. Objectives and sub-objectives established prior to designing the device.

Objective

Sub-Objective
Biocompatible

Safe

No risk of organ damage
Minimally Invasive
Handheld

User Friendly
Easy to Operate
Low Cost
Marketable
Time Efficient

We decided that for a safe device to be created, the product must be biocompatible, allow
for minimal organ damage, and maintain the minimally invasive nature of the current
5

laparoscopic procedure. The current techniques result in organ damage if not used
properly, so the device needs to improve upon the safety of the procedure without
becoming a more invasive procedure.
To produce a device that is user friendly, we determined that the device needs to be easy
to operate to prevent operator mistakes, as well as handheld. We need to create a device
that does not change the procedure for the surgeons and can be operated using one hand.
Finally, we believed our third objective, producing an instrument that would be
marketable, could be achieved by creating a device that was low cost and time efficient.
If our new device is not comparable in price and efficiency to the current products on the
market, surgeons will be unlikely to switch to our device, even if it is safer.

Device Functions and Specifications
Based on current technologies and our design objectives, the main functions of our device
can be split into two categories: achieves pneumoperitoneum and increases patient safety.
To achieve pneumoperitoneum, we determined our device functions to be as follows: cuts
through outer abdominal wall efficiently, enters through a small incision, and inflates the
peritoneal cavity (Table 2). To increase patient safety, we determined the functions of
our device to be as follows: provides buffer to prevent organ damage, maintains the same
procedure for the surgeons, and safely removes buffer (Table 2). For every function our
device must fulfill, we determined a corresponding metric to determine the degree to
which the device will complete the function requirement.
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Table 2. Device functions and corresponding specification values.

Category

Function

Metric

Unit

Margin
al Value

Ideal
Value

Achieves
Pneumoperitoneum

Cuts through
abdominal
wall

Force
required
for entry

Newtons
(N)

68.67
[10]

68.67
[10]

Achieves
Pneumoperitoneum

Enters
through
small
incision

Size of
incision

Millimeters
(mm)

12 [11]

10 [11]

Achieves
Pneumoperitoneum

Inflates the
cavity

Presence
of port

Binary yes
or no

Increases Safety

Provides
buffer to
protect
organs

Presence
of buffer
component

Binary yes
or no

Increases Safety

Maintains
procedure

Alters
procedure
methods

Binary yes
or no

Increases Safety

Removes
buffer

Force
required
for buffer
removal

Newtons
(N)

1N
Less
than
removal
force for
current
model

3N
Less than
removal
force for
current
model.

Our design must complete a number of functions in order to compete with the current
Veress needles and solve the problem we have identified. As the initial entry process is
carried out, the device must first be able to penetrate the multiple layers of abdominal
tissue under the average pressure that surgeons currently apply. The force generally
7

applied by a surgeon to penetrate the tissues is 68.67N [10]. We do not want to alter the
force required because this method has become routine. Although our design ideally will
give the surgeon the ability to apply a greater force while still not damaging the inner
tissues, the transition to using our device should be simple and we want the process to
feel the same for the surgeon.
The device must also fit through a single small incision. Laparoscopic procedures begin
by making a 12mm incision with a scalpel to put the Veress needle through [11]. Our
device needs to be small enough to fit through that same incision; we must keep the
cannula portion of the device small enough that this specification will not change.
Next, we want a buffer to deploy to protect the inner tissues. This function is binary:
either the buffer will deploy or it will not.
Then, once safely positioned inside the cavity, the device must act like port to allow for
the flow of carbon dioxide to inflate the peritoneal cavity. This function is also binary, as
the device will either allow for the passage of carbon dioxide or it will not.
Finally, our device must be able to remove the buffer in order to safely exit the body. The
buffer must come off the device to ensure safe removal with a force less than or equal to
the average force required for current model removal. The specification for these values
were determined during validation testing.

Design Requirements
The most important requirements for our design were determined based on our objectives
and functions, stemming from research and current models. The top requirements for our
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device were as follows: must cut through tissues, must inflate the peritoneal cavity,
requires a small incision for entry, and must have a buffer component (Table 3). The
requirements were all determined with associated specification values that will serve as a
baseline for our evaluations.
Table 3. Design requirements and specifications.

Design Requirements

Specification

Penetrates through tissues

68.67 N [10]

Provides port or cavity inflation

Binary (port presence)

Device size

12 mm midline incision [11]

Buffer component

Can withstand 68.67 N of entry force [10]

Protects internal tissue

Binary

Buffer withdrawal force

To be determined through testing - must
be less than average force of the current
model in order to ensure the buffer “pops”
off

The three critical components of our design that must be at least equivalent to the current
design of a Veress needle are its ability to cut through tissues, inflate the peritoneal
cavity, and do so through a small incision. The device must cut through tissues when a
force of no greater than 68.67N is applied [10], inflate the cavity successfully which is
indicated by the presence of carbon dioxide in the cavity, and the device must be inserted
through an incision no larger than 12mm [11]. These design requirements are
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successfully fulfilled by the current Veress needle models and are crucial to the
procedure.
To improve the current Veress needle, we added the requirements of a buffer component
to protect the internal organs. This requirement stems from our objective of safety and
addresses the main problem with the current Veress needle models of unwanted injury to
inner structures. The buffer component must withstand the force of 68.67N and continue
to protect the internal tissues when this force is applied [10]. In order for our design to
function, the buffer must “pop” off the end of the device upon removal of the inner stylet.
The buffer must come off of the stylet easily, with less force than is required for standard
device removal. We will determine what force is required to remove a Veress needle
from the body and compare this value to the force required for the buffer to come off the
stylet to ensure it is less.
These design requirements will be thoroughly evaluated individually to ensure the
success of our device.
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Proposed Design
Pictured below is a 3D model and dimensional drawing of the final design of our
prototype created with SolidWorks. The length of the cannula is 160mm and the diameter
of the buffer is 6.35mm (Figure 3).

Figure 3. (Top) SolidWorks model of final design showing protective buffer (1), stylet with air port (2), sharp outer
cannula (3), spring loaded handle (4), and pin for stylet/buffer retraction (5). (Bottom) Dimensional drawing of final
design with buffer diameter and length of cannula noted in millimeters.

Entry and Insufflation
The buffer is attached at the end of the stylet and will begin inside of the cannula’s shaft,
as the sharp beveled tip of the cannula pierces through tissues prior to the abdominal
cavity. As this occurs, the end of the stylet will be under pressure by a spring located
inside of the handle. Once the tip of the needle reaches the open space inside of the
abdomen, the spring in the handle will force the stylet/buffer combination out of the
cannula. The buffer will then expand, so that it is extended around the entirety of the
sharp cannula’s outer surface, thus protecting the internal tissues of the patient from
11

contact with the sharp tip of the needle. Once the tip of the needle is inside the patient’s
abdominal cavity, air will be pumped from the handle-end of the stylet, travel through the
hollow stylet, through an air port, and into the cavity of the patient, allowing for the
successful insufflation necessary for the laparoscopic procedure.
Retraction of Stylet Prior to Entry
An issue with the rounded dome buffer component that we designed was that since the
diameter of the buffer is larger than that of the cannula, once it is deployed out of the
cannula, it will not be easily retracted back into the cannula. In order to account for this, a
handle was designed and manufactured from PLA that contained a pin to keep the
buffer/stylet component inside of the cannula prior to becoming in contact with the
exterior tissues of the patient (Figure 4).

Figure 4. Handle of prototype, containing a pin to keep the stylet and buffer
component retracted (shown by red arrow) prior to the tip of the needle coming in
contact with external tissues of patient.

The pin seen above keeps the spring inside of the handle compressed, and thus the stylet
connected to it inside of the shaft of the cannula. This pin serves as a way to prevent
premature buffer deployment. Upon contact between the external tissues of the patient
and the tip of the needle, the pin will keep the buffer/stylet component retracted. Once the
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tip of the needle comes in contact with the patient’s external tissues, the pin will be
removed, as the external tissues of the patient will be preventing deployment of the
buffer. Upon entry into the abdominal cavity, the pressure that was exerted upon the tip
of the needle, keeping the buffer component inside of the cannula, will no longer be
present. This will allow for the buffer to be released into the cavity, encompassing the
sharp cannula’s outer surface, and thus protecting the patient’s internal tissues.
Removal of Needle
Once the buffer has been deployed, and the abdominal cavity has been successfully
insufflated, the needle will need to be removed. Due to the greater diameter of the buffer
than the cannula, the needle cannot be taken out of the abdomen of the patient all at once.
To account for this, the handle was made in two pieces that snap into one another and can
be separated upon successful insufflation (Figure 5).

Figure 5. Prototype showing handle opened up, allowing for removal of stylet component. Red arrow shows
direction of pulling done by user to remove stylet component.

Once the cavity has been inflated, the top of the handle of our device will be removed.
This will allow for the stylet to be pulled through the cannula, and thus out of the body of
the patient. In doing so, the buffer component will be forced off of the end of the stylet
and will remain inside the patient’s body. To ensure the patient’s safety, the buffer
13

component will be fabricated from a biodegradable material that exhibits the necessary
flexibility and durability of our buffer component. Once the buffer has been removed
from the stylet and the stylet has been removed from the patient, the cannula can easily
be taken out of the cavity, in a traditional needle fashion.
Final Prototype
Our final prototype combined all of these components (Figure 6). The prototype was
fabricated out of stainless steel for the cannula, PLA for the handle, and Repro Rubber
for the buffer. The buffer was created using a dome mold that the Repro Rubber was
poured into, which resulted in the flexible but durable buffer prototype. We used the
stylet and spring component from a current Veress needle.
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Figure 6. Final prototype iteration. The buffer (1), stylet (2), cannula (3), spring (4), and handle (5) fit
together to create a working prototype. The handle is shown in a cross sectional view.

Validation of Design
Based on our top design requirements of cutting through tissues, inflating the peritoneal
cavity, requiring a small incision for entry, having a buffer component that protects the
internal tissues, and having the buffer safely exit the body, we developed corresponding
evaluation methods to ensure completion of these requirements (Table 4).
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Table 4. Evaluation methods for top five design requirements.

Design
Requirements

Specification

Evaluation

Cuts through
tissues

3 attempts

Use practice tissue to determine ease
of access

Inflates cavity

Binary

Open the valve and blow through the
port to ensure the buffer does not
prevent air flow

Device size

12 mm midline
incision [11]

Cut a standard incision for
laparoscopic surgery in practice
tissue to ensure that the device fits
inside

Buffer
component

68.67 N or 15.44 lbs
[10]

Use practice tissue to ensure that the
buffer prevents the cannula from
puncturing tissues. Use scale to
determine if the buffer can handle the
standard force.

Buffer safely
exits the body

TBD – the force
required to remove
needle from body

Ensure that the buffer component
does not break off when this force is
applied.

A practice tissue was used to test the device’s ability to cut through tissue and the
device’s size. To test the device’s ability to cut through the tissue, we created the ‘Hot
Glue Test’. For the hot glue test, we put hot glue on a piece of paper and then placed the
practice tissue on top. We then pierced through the practice tissue with the cannula
without applying excessive force for fifteen trials. After each trial, we removed the
practice tissue and checked the hot glue for a clear puncture mark. If there was a mark in
the glue, the trial was considered successful. We successfully pierced through the tissues
on the first attempt for all trials; therefore, our device meets the requirement of piercing
through the tissues within three attempts.
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Since we did not change any of the insufflation mechanisms, validating that our device
inflated the cavity was binary; we tested to see if it allowed for air flow or if the buffer
prevented air flow. To test this, we opened the valve attached to the handle and blew
through the handle where the carbon dioxide would be hooked up. With the buffer
attached, our device allowed for air flow.
To ensure that our device maintained the minimally invasive nature of the procedure, our
device had to fit through a 12mm incision. To test this, we made a 12mm incision in
practice tissue and inserted our device. Since the diameter of our cannula was 4mm, it fit
through the 12mm incision with ease.
To verify that our buffer successfully protected the tissues, we performed the ‘Hot Glue
Test’ with the buffer encompassing the cannula. The buffer was successful in preventing
puncturing for all fifteen trials. Following this test, we tested to ensure that the buffer
could handle the standard force applied during laparoscopic initial entry, which is
68.67N. To test this, we pushed our device with the buffer attached into a scale until the
scale began to give inaccurate results. This value was 15.6lbs which can be converted to
69.4N. Since this value is greater than the 68.67N applied during surgery, we concluded
that our buffer would successfully prevent the cannula from puncturing tissues.
Since our buffer is designed to pop off of the stylet upon removal from the body, we
tested to ensure that it would not require excessive force during removal. The first step in
this test was to remove the Veress needle from practice tissue using a force gauge to
determine the average force required to remove the needle from the tissues. The needle
was removed five times by each of us for a total of fifteen trials resulting in an average
16

removal force of 3.5N. To ensure that the buffer popped off of the stylet without
exceeding this 3.5N force, we used the force gauge to pull the stylet up against the
cannula until the buffer popped off. We had a total of fifteen trials resulting in an average
force of 1.1N. Since the buffer popped off at a force less than 3.5N, we concluded that
the buffer will be safely popped off of the stylet during removal without the need to apply
extra force.
Since we did not alter the main mechanisms of the device, the overall procedure was not
altered significantly. However, we wanted to ensure that the weight of the device was not
altered significantly, as that would affect the force required to successfully complete the
procedure. We weighed the current Veress needle, which was found to be 0.02lbs.
According to the literature, a Veress needle should weigh less than 4lbs [12]. Our
completed prototype was found to weigh 0.03lbs, which is within the specification range,
so we determined this would not affect the procedure significantly.

Anticipated Regulatory Pathway
If we were to take this project further and go through the process of attempting to get FDA
approval, we would go the route of the 510(k) premarket notification similarly to the GRIAlleset Veress needle. The GRI-Alleset Veress needle 510(k) premarket notification was
filed by GRI Medical and Electronic Technology Co., Ltd., 1805 Honggao Road, Xiuzhou
Industry Zone, Jiaxing, China 214031 under the 510(k) number K172835. The device was
filed with product code HIF (insufflator, laparoscopic) with a common name of Veress
Needle and regulation name of Laparoscopic insufflator. The regulation number of the
device was 21 CFR 884.1730 and it was classified as a class II device. The device was
reviewed by the Obstetrics and Gynecology panel [13].
17

The GRI-Alleset Veress needle was found to be substantially equivalent to the Endopath
Ultra Veress needle produced by Ethicon Endosurgery, Inc. Both devices are Class II
laparoscopic insufflators intended to be used by surgeons in the operating room. The results
of the performance testing determined that the GRI-Alleset Veress Needle is substantially
equivalent to the Ethicon Endopath Ultra Veress Needle. Mechanical bench testing
involving gas flow, leakage, max puncture force, rotational valve operation, stylet
alignment, stylet strength, connector fitting, and audible rate were conducted and found to
be equivalent to the predicate device.
The GRI-Alleset Veress needle is similar to our device as it’s intended use is as a
“disposable, single-use, sterile surgical instrument used during minimally invasive surgery
for the establishment of peritoneum of the abdominal cavity prior to abdominal surgery.”
Both devices include a stainless-steel needle with a spring-loaded inner stylet attached to a
plastic handle with a red safety indicator. Where our devices differ is in our added buffer
component that we intend to leave in the body following the procedure. This added element
may add complications to our FDA approval route in comparison to similar devices.

18

References
[1] N. S. Blencowe, R. Waldon and M. N. Vipond, "Management of patients after
laparoscopic procedures," BMJ, p. 360, 08 February 2018.
[2] J. Fouogue, R. Tchounzou and F. Fouelifack, "Evaluation of patients' satisfaction
after laparoscopic surgery in a tertiary hospital in Cameroon (Africa)," The Pan
African Medical Journal, vol. 28, no. 216, 2017.
[3] B. S. M. Chern, S. Lakhotia, C. Kiat Khoo and A. Yew Ming Siow, "Single
incision laparoscopic surgey in gynecology: Evolution, current trends, and future
perspectives," Gynecology and Minimally Invasive Therapy, vol. 1, no. 1, pp. 918, 2012.
[4] Memorial Sloan Kettering Cancer Center, “Diagnostic Laparoscopy: About Your
Diagnostic Laparoscopy,” mskcc.org, Aug. 30, 2016.
[5] T. Vellinga, S. De Alwis, Y. Suzuki and J. Einarsson, "Laparoscopic Entry: The
Modified Alwis Method and More," Reviews in Obstetrics and Gynecology, vol.
2, no. 3, pp. 193-198, 2009.
[6] A. Toro, M. Mannino, G. Cappello, A. Di Stefano and I. Di Carlo, "Comparison of
Two Entry Methods for Laparoscopic Port Entry: Technical Point of View,"
Diagnostic and Therapeutic Endoscopy, p. 7, 2012.
[7] S. Krishnakumar and P. Tambe, "Entry complications in laparoscopic surgery,"
US National Library of Medicine National Institutes of Health, 2009.
[8] R. Mohajer, “Veress needle with illuminated tip and cavity penetration indicator,”
U. S. Grant 8838206B2, 16 Sep., 2014.
[9] R. Marks, C. Edwards, “Proximity detector with a medical instrument,” U. S.
Grant 5080104A, 14 Jan., 1992
[10] The Center for Innovative GYN Care, Laparoscopic Procedure, 2018.
[11] M. Perrin and A. Fletcher, "Laparoscopic abdominal surgery," Continuing
Education in Anaesthesia Critical Care and Pain, vol. 4, no. 4, pp. 107-110, 2004.
[12] G. A. Vilos, A. Ternamian, J. Dempster and P. Laberge, "Laparoscopic Entry: A
Review of Techniques, Technologies, and Complications," SOGC Clinical
Practice Guideline, vol. 193, pp. 433-447, 2007.
[13] GRI Medical And Electronic Technology Co., Ltd, “GRI-Alleset Veress Needle,”
510(K) Number K172835, 19 Sept., 2017

19

Appendix A: Current Patents

Figure A-1. Diagram of patent with an indicator light (32) switched on by
the positioning of the spring (20) which triggers the switch (30) [9]

Figure A-2. Diagrammatic illustration of a surgeon's scalpel in a holder
with a miniature acoustic transducer, with an expanded view of the
electronic circuit [10]
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Appendix B: Objective and Sub-Objective Trees

Figure B-1. Objective tree for sub-objectives relating to the main function of safe.

Figure B-2. Objective tree for sub-objectives relating
to the main function of marketable.

Figure B-3. Objective tree for sub-objectives relating to the main
function of user friendly.

B-1

Appendix C: Decision Matrices

Figure C-1. Screening decision matrix. All of the potential designs were evaluated based on their satisfaction of the objectives.
Any design that did not reduce the risk of organ damage were immediately eliminated. The top choice was the design
incorporating ultrasonic proximity sensors.

Figure C-2. Weighted decision matrix. The top designs determined by the screening matrix were weighted based on their
satisfaction of the objectives. The top design was the design combining the elements from the umbrella and the ultrasonic
proximity sensor.
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Appendix D: Other Designs Not Developed Further

Figure D-1. Peritoneal cavity entry device concept design,
incorporating an ultrasonic proximity sensor. Design was
determined to not be feasible for the scope of our project.

D-1

Figure D-2. Peritoneal cavity entry device concept design incorporating large guide, reducing the
potential for human error. Design was determined to not be user friendly for the surgeon.

Figure D-3. Peritoneal cavity entry device concept design that the final design we agreed upon was developed
from. Incorporates a buffer between the sharp cannula and the internal tissues.
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Figure D-4. Peritoneal cavity entry device concept design incorporating a
suctioning technique. A device on the market was identified as already utilizing
this technique, and therefore the device was determined to be an infringement
upon IP.
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